Invincible, but Not Invisible: Imaging Approaches Toward In Vivo Detection of Cancer Stem Cells

2008 ◽  
Vol 26 (17) ◽  
pp. 2901-2910 ◽  
Author(s):  
Lori S. Hart ◽  
Wafik S. El-Deiry

With evidence emerging in support of a cancer stem-cell model of carcinogenesis, it is of paramount importance to identify and image these elusive cells in their natural environment. The cancer stem-cell hypothesis has the potential to explain unresolved questions of tumorigenesis, tumor heterogeneity, chemotherapeutic and radiation resistance, and even the metastatic phenotype. Intravital imaging of cancer stem cells could be of great value for determining prognosis, as well as monitoring therapeutic efficacy and influencing therapeutic protocols. Cancer stem cells represent a rare population of cells, as low as 0.1% of cells within a human tumor, and the phenotype of isolated cancer stem cells is easily altered when placed under in vitro conditions. This represents a challenge in studying cancer stem cells without manipulation or extraction from their natural environment. Advanced imaging techniques allow for the in vivo observation of physiological events at cellular resolution. Cancer stem-cell studies must take advantage of such technology to promote a better understanding of the cancer stem-cell model in relation to tumor growth and metastasis, as well as to potentially improve on the principles by which cancers are treated. This review examines the opportunities for in vivo imaging of putative cancer stem cells with regard to currently accepted cancer stem-cell characteristics and advanced imaging technologies.

2015 ◽  
Vol 22 (6) ◽  
pp. T199-T208 ◽  
Author(s):  
Maho Shibata ◽  
Michael M Shen

The cancer stem cell model proposes that tumors have a hierarchical organization in which tumorigenic cells give rise to non-tumorigenic cells, with only a subset of stem-like cells able to propagate the tumor. In the case of prostate cancer, recent analyses of genetically engineered mouse (GEM) models have provided evidence supporting the existence of cancer stem cells in vivo. These studies suggest that cancer stem cells capable of tumor propagation exist at various stages of tumor progression from prostatic intraepithelial neoplasia (PIN) to advanced metastatic and castration-resistant disease. However, studies of stem cells in prostate cancer have been limited by available approaches for evaluating their functional properties in cell culture and transplantation assays. Given the role of the tumor microenvironment and the putative cancer stem cell niche, future studies using GEM models to analyze cancer stem cells in their native tissue microenvironment are likely to be highly informative.


2013 ◽  
Vol 105 (8) ◽  
pp. 551-562 ◽  
Author(s):  
Sara M. Nolte ◽  
Chitra Venugopal ◽  
Nicole McFarlane ◽  
Olena Morozova ◽  
Robin M. Hallett ◽  
...  

2011 ◽  
Author(s):  
Md. Al Mamun ◽  
Md. Shaifur Rahman ◽  
Md. Fahmid Islam ◽  
Ummay Honi ◽  
Mahbub E. Sobhani

From the conventional Bird’s eye, cancer initiation and metastasis are generally intended to be understood beneath the light of classical clonal genetic, epigenetic and cancer stem cell model. But inspite decades of investigation, molecular biology has shown hard success to give Eagle’s eye in unraveling the riddle of cancer. And it seems, tiring Tom runs in vague behind naughty Jerry.


2016 ◽  
Vol 62 (3) ◽  
pp. 228-238 ◽  
Author(s):  
Y.S. Kim ◽  
A.M. Kaidina ◽  
J.H. Chiang ◽  
K.N. Yarygin ◽  
A.Yu. Lupatov

This systematic review aims to analyze molecular markers of cancer stem cells. Only studies that confirmed tumor-initiating capacity of this population by in vivo assay in immunodeficient mice were included. Final sample of papers that fully correspond with initial aim consists of 97 original studies. The results of their analysis reveal that markers commonly used for cancer stem cells deriving were as follows: CD133, СD44, ALDH, CD34, CD24 and EpCAM. The review also contains description of molecular features of some cancer stem cell markers, modern approaches to cancer treatment by targeting this population and brief assessment of cancer stem cell theory development.


2014 ◽  
Vol 14 (3) ◽  
pp. 275-291 ◽  
Author(s):  
Antonija Kreso ◽  
John E. Dick

2012 ◽  
Author(s):  
Ling Chen ◽  
Shuichi Matsuda ◽  
Tomonari Kasai ◽  
Yuh Sugii ◽  
Masashi Okada ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document